Corbus Pharmaceuticals Reports 2019 Second Quarter Financial Results and Provides Clinical and Corporate Updates 

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. SPCX
2. NVDA
3. ACN
4. USO
5. APGE
6. DFTX
7. GOOGL
8. MU
9. IBM
10. HOOD

Go back to Corbus Pharmaceuticals Reports 2019 Second Quarter Financial Results and Provides Clinical and Corporate Updates 

Corbus Pharma (CRBP) Reports Q2 EPS of $0.03

August 8, 2019 7:16 AM EDT

Corbus Pharma (NASDAQ: CRBP) reported Q2 EPS of $0.03, versus ($0.21) reported last year. Revenue for the quarter came in at $29.1 million, versus $853 thousand reported last year.

For earnings history and earnings-related data on Corbus Pharma (CRBP) click here.

... More